Baird Financial Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-28,872
| Closed | -$466K | – | 1773 |
|
|
2023
Q3 | $466K | Buy |
28,872
+21,112
| +272% | +$341K | ﹤0.01% | 1357 |
|
|
2023
Q2 | $322K | Sell |
7,760
-6,523
| -46% | -$271K | ﹤0.01% | 1480 |
|
|
2023
Q1 | $859K | Sell |
14,283
-1,778
| -11% | -$107K | ﹤0.01% | 1142 |
|
|
2022
Q4 | $1.18M | Buy |
16,061
+230
| +1% | +$16.9K | ﹤0.01% | 1024 |
|
|
2022
Q3 | $1.2M | Buy |
15,831
+85
| +0.5% | +$6.46K | ﹤0.01% | 991 |
|
|
2022
Q2 | $1.09M | Buy |
+15,746
| New | +$1.09M | ﹤0.01% | 1048 |
|
|
2021
Q2 | – | Sell |
-8,619
| Closed | -$1.14M | – | 1765 |
|
|
2021
Q1 | $1.14M | Buy |
8,619
+1,720
| +25% | +$227K | ﹤0.01% | 1081 |
|
|
2020
Q4 | $1.19M | Sell |
6,899
-888
| -11% | -$154K | ﹤0.01% | 949 |
|
|
2020
Q3 | $867K | Buy |
7,787
+3,471
| +80% | +$386K | ﹤0.01% | 985 |
|
|
2020
Q2 | $256K | Buy |
4,316
+425
| +11% | +$25.2K | ﹤0.01% | 1353 |
|
|
2020
Q1 | $262K | Buy |
3,891
+1,345
| +53% | +$90.6K | ﹤0.01% | 1245 |
|
|
2019
Q4 | $215K | Sell |
2,546
-827
| -25% | -$69.8K | ﹤0.01% | 1447 |
|
|
2019
Q3 | $252K | Buy |
+3,373
| New | +$252K | ﹤0.01% | 1366 |
|